Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia.
Ann Hematol
; 101(10): 2263-2270, 2022 Oct.
Article
in En
| MEDLINE
| ID: mdl-35997804
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridazines
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Antineoplastic Agents
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2022
Type:
Article
Affiliation country:
Spain